Financhill
Back

ITeos Therapeutics Quote, Financials, Valuation and Earnings

ITeos Therapeutics Price Quote

$11.80
+0.29 (+2.52%)
(Updated: May 3, 2024 at 11:20 AM ET)

ITeos Therapeutics Key Stats

Sell
40
ITeos Therapeutics (ITOS) is a Sell

Day range:
$11.26 - $11.89
52-week range:
$8.20 - $18.24
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.22
P/B ratio:
0.72%

Volume:
265.5K
Avg. volume:
289.8K
1-year change:
-14.17%
Market cap:
$412.6M
Revenue:
$12.6M
EPS:
$-3.15

How Much Does ITeos Therapeutics Make?

Data Unavailable

Is ITeos Therapeutics Growing As A Company?

Data Unavailable

ITeos Therapeutics Stock Price Performance

What Is ITeos Therapeutics 52-Week High & Low?

ITeos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ITeos Therapeutics?

Is ITeos Therapeutics Cash Flow Positive?

  • What Is ITOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.8M
  • What Is ITeos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.1M
  • What Is ITeos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $72.7M

ITeos Therapeutics Return On Invested Capital

Data Unavailable

ITeos Therapeutics Earnings Date & Stock Price

ITeos Therapeutics Competitors

ITeos Therapeutics Dividend Yield

Data Unavailable

ITeos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.04%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 34.40
Upside from Last Price: 198.87%

Major Shareholders

  • How many ITOS shares are owned by institutional investors?
    43.2M ITOS shares are owned by institutional investors
  • How many ITOS shares are owned by insiders?
    288.2K ITOS shares are owned by insiders